Cargando…

Iron Oxide as an MRI Contrast Agent for Cell Tracking

Iron oxide contrast agents have been combined with magnetic resonance imaging for cell tracking. In this review, we discuss coating properties and provide an overview of ex vivo and in vivo labeling of different cell types, including stem cells, red blood cells, and monocytes/macrophages. Furthermor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korchinski, Daniel J., Taha, May, Yang, Runze, Nathoo, Nabeela, Dunn, Jeff F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597836/ https://www.ncbi.nlm.nih.gov/pubmed/26483609 http://dx.doi.org/10.4137/MRI.S23557

Ejemplares similares

Superparamagnetic Iron Oxide Nanoparticles as MRI contrast agents for Non-invasive Stem Cell Labeling and Tracking
por: Li, Li, et al.
Publicado: (2013)

Detecting Deoxyhemoglobin in Spinal Cord Vasculature of the Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis Using Susceptibility MRI and Hyperoxygenation
por: Nathoo, Nabeela, et al.
Publicado: (2015)

Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models
por: Nathoo, Nabeela, et al.
Publicado: (2014)

Contribution of macrophages in the contrast loss in iron oxide-based MRI cancer cell tracking studies
por: Danhier, Pierre, et al.
Publicado: (2017)

Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2023)

CARS microscopy for the visualization of micrometer-sized iron oxide MRI contrast agents in living cells
por: Rago, Gianluca, et al.
Publicado: (2011)

Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T(2) Contrast Agents for MRI
por: Martínez-González, Raquel, et al.
Publicado: (2016)

Effects of iron oxide nanoparticles as T(2)-MRI contrast agents on reproductive system in male mice
por: Yang, Heyu, et al.
Publicado: (2022)

New MRI contrast agents based on silicon nanotubes loaded with superparamagnetic iron oxide nanoparticles
por: Gonzalez-Rodriguez, Roberto, et al.
Publicado: (2018)

Polymer-coated superparamagnetic iron oxide nanoparticles as T(2) contrast agent for MRI and their uptake in liver
por: Ali, Lamiaa MA, et al.
Publicado: (2017)

Fluorine-19 MRI Contrast Agents for Cell Tracking and Lung Imaging
por: Fox, Matthew S., et al.
Publicado: (2016)

Magnetic core–shell nanowires as MRI contrast agents for cell tracking
por: Martínez-Banderas, Aldo Isaac, et al.
Publicado: (2020)

Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents
por: Di Marco, Mariagrazia, et al.
Publicado: (2007)

Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent
por: Deng, Li-Hua, et al.
Publicado: (2021)

Effects of PEG Chain Length on Relaxometric Properties of Iron Oxide Nanoparticles-Based MRI Contrast Agent
por: Ge, Jianxian, et al.
Publicado: (2022)

Comparing the signal enhancement of a gadolinium based and an iron-oxide based contrast agent in low-field MRI
por: van Zandwijk, Jordy K., et al.
Publicado: (2021)

Ultrasmall cationic superparamagnetic iron oxide nanoparticles as nontoxic and efficient MRI contrast agent and magnetic-targeting tool
por: Uchiyama, Mayara Klimuk, et al.
Publicado: (2015)

Assessment of Gold-Coated Iron Oxide Nanoparticles as Negative T2 Contrast Agent in Small Animal MRI Studies
por: Iancu, Stefania D, et al.
Publicado: (2020)

Preparation and characterization of peptide modified ultrasmall superparamagnetic iron oxides used as tumor targeting MRI contrast agent
por: Yin, Jie, et al.
Publicado: (2019)

MRI Contrast Agents in Glycobiology
por: Geraldes, Carlos F. G. C., et al.
Publicado: (2022)

The Effectiveness of Ferritin as a Contrast Agent for Cell Tracking MRI in Mouse Cancer Models
por: Lee, Chan Wha, et al.
Publicado: (2017)

An Efficient T (1) Contrast Agent for Labeling and Tracking Human Embryonic Stem Cells on MRI
por: Haedicke, Inga E., et al.
Publicado: (2019)

Mesoporous Silica-Coated Hollow Manganese Oxide Nanoparticles as Positive T(1) Contrast Agents for Labeling and MRI Tracking of Adipose-Derived Mesenchymal Stem Cells
por: Kim, Taeho, et al.
Publicado: (2011)

Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
por: Johnson, Thomas W., et al.
Publicado: (2016)

Macromolecules with Different Charges, Lengths, and Coordination Groups for the Coprecipitation Synthesis of Magnetic Iron Oxide Nanoparticles as T(1) MRI Contrast Agents
por: Tao, Cheng, et al.
Publicado: (2019)

Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque
por: Evans, Rhiannon J., et al.
Publicado: (2020)

Impact of metallic trace elements on relaxivities of iron-oxide contrast agents
por: Ma, Ji, et al.
Publicado: (2019)

Assessing the Efficacy of Nano- and Micro-Sized Magnetic Particles as Contrast Agents for MRI Cell Tracking
por: Taylor, Arthur, et al.
Publicado: (2014)

New Strategies to Prolong the In Vivo Life Span of Iron-Based Contrast Agents for MRI
por: Antonelli, Antonella, et al.
Publicado: (2013)

Contrast agents for hepatic MRI
por: Morana, Giovanni, et al.
Publicado: (2007)

T(1)–T(2) Dual-modal MRI contrast agents based on superparamagnetic iron oxide nanoparticles with surface attached gadolinium complexes
por: Szpak, Agnieszka, et al.
Publicado: (2014)

Amalgamation of complex iron(III) ions and iron nanoclusters with MWCNTs as a route to potential T(2) MRI contrast agents
por: Kuźnik, Nikodem, et al.
Publicado: (2015)

Correction: Assessing the Efficacy of Nano- and Micro-Sized Magnetic Particles as Contrast Agents for MRI Cell Tracking
Publicado: (2015)

Carbon-coated iron oxide nanoparticles as contrast agents in magnetic resonance imaging
por: Bae, Hongsub, et al.
Publicado: (2012)

Cubic Iron Core–Shell Nanoparticles Functionalized to Obtain High-Performance MRI Contrast Agents
por: Volokhova, Maria, et al.
Publicado: (2022)

Targeted Imaging of Lung Cancer with Hyperpolarized (129)Xe MRI Using Surface-Modified Iron Oxide Nanoparticles as Molecular Contrast Agents
por: Kimura, Atsuomi, et al.
Publicado: (2022)

Gadolinium-labelled iron/iron oxide core/shell nanoparticles as T(1)–T(2) contrast agent for magnetic resonance imaging
por: Wang, Kaili, et al.
Publicado: (2018)

MRI Contrast Agents for Pharmacological Research
por: Terreno, Enzo, et al.
Publicado: (2015)

Magnetic Nanomaterials as Contrast Agents for MRI
por: Caspani, Sofia, et al.
Publicado: (2020)

Magnetic Nanoparticles as MRI Contrast Agents
por: Avasthi, Ashish, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s8s23dr19jna7r0eggor0qpvep